Are GOLD ABCD groups better associated with health status and costs than GOLD 1234 grades? A cross-sectional study

被引:23
作者
Boland, Melinde R. S. [1 ,2 ]
Tsiachristas, Apostolos [1 ,2 ]
Kruis, Annemarije L. [3 ]
Chavannes, Niels H. [3 ]
Rutten-van Molken, Maureen P. M. H. [1 ,2 ]
机构
[1] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands
[2] Erasmus Univ, Dept Hlth Policy & Management, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands
来源
PRIMARY CARE RESPIRATORY JOURNAL | 2014年 / 23卷 / 01期
关键词
chronic obstructive pulmonary disease; economics; primary care; OBSTRUCTIVE PULMONARY-DISEASE; COPD; CLASSIFICATION; VALIDATION; MORTALITY; SF-36;
D O I
10.4104/pcrj.2014.00002
中图分类号
R1 [预防医学、卫生学];
学科分类号
100235 [预防医学];
摘要
Aims: To investigate the association of the GOLD ABCD groups classification with costs and health-related quality of life (HR-QoL) and to compare this with the GOLD 1234 grades classification that was primarily based on lung function only. Methods: In a cross-sectional study, we selected patients diagnosed with chronic obstructive pulmonary disease (COPD) from electronic medical records of general practices. Multi-level analysis was used with costs (medication, primary care, healthcare, societal), disease-specific and generic HR-QoL as independent variables. Either the new or the old GOLD stages were included in the analysis together with several covariates (age, gender, living situation, co-morbidity, self-efficacy, smoking, education, employment). Results: 611 patients from 28 general practices were categorised as GOLD-A (n=333), GOLD-B (n=110), GOLD-C (n=80) and GOLD-D (n=88). Patients in the GOLD-B and GOLD-D groups had the highest prevalence of co-morbidities and the lowest level of physical activity, self-efficacy, and employment. The models with GOLD ABCD groups were more strongly related to and explained more variance in costs and in disease-specific and generic HR-QoL than the models with GOLD 1234 grades. The mean Clinical COPD Questionnaire score worsened significantly, with scores 1.04 (GOLD-B), 0.4 (GOLD-C) and 1.21 (GOLD-D) worse than for patients in GOLD-A. Healthcare costs per patient were significantly higher in GOLD-B (72%), GOLD-C (74%) and GOLD-D (131%) patients than in GOLD-A patients. Conclusions: The GOLD ABCD groups classification is more closely associated with costs and HR-QoL than the GOLD 1234 grades classification. Furthermore, patients with GOLD-C had a better HR-QoL than those with GOLD-B but the costs of the two groups did not differ. (C) 2014 Primary Care Respiratory Society UK. All rights reserved.
引用
收藏
页码:30 / 37
页数:8
相关论文
共 29 条
[1]
Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations [J].
Aaronson, NK ;
Muller, M ;
Cohen, PDA ;
Essink-Bot, ML ;
Fekkes, M ;
Sanderman, R ;
Sprangers, MAG ;
Velde, AT ;
Verrips, E .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1055-1068
[2]
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort [J].
Agusti, Alvar ;
Edwards, Lisa D. ;
Celli, Bartolome ;
MacNee, William ;
Calverley, Peter M. A. ;
Muellerova, Hana ;
Lomas, David A. ;
Wouters, Emiel ;
Bakke, Per ;
Rennard, Steve ;
Crim, Courtney ;
Miller, Bruce E. ;
Coxson, Harvey O. ;
Yates, Julie C. ;
Tal-Singer, Ruth ;
Vestbo, Jorgen .
EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (03) :636-646
[3]
[Anonymous], 2010, LAN ZORGSTANDAARD CO
[4]
[Anonymous], 2010, HANDLEIDING KOSTENON
[5]
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].
Bestall, JC ;
Paul, EA ;
Garrod, R ;
Garnham, R ;
Jones, PW ;
Wedzicha, JA .
THORAX, 1999, 54 (07) :581-586
[6]
A comparison of the EQ-5D and SF-6D across seven patient groups [J].
Brazier, J ;
Roberts, J ;
Tsuchiya, A ;
Busschbach, J .
HEALTH ECONOMICS, 2004, 13 (09) :873-884
[7]
The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients [J].
Charlson, Mary E. ;
Charlson, Robert E. ;
Peterson, Janey C. ;
Marinopoulos, Spyridon S. ;
Briggs, William M. ;
Hollenberg, James P. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2008, 61 (12) :1234-1240
[8]
Chavannes Niels H, 2009, Prim Care Respir J, V18, P171, DOI 10.3132/pcrj.2009.00003
[9]
GIPdatabank, GIPD
[10]
Han MK, 2012, LANCET RESP MED, V1, P1, DOI DOI 10.1016/52213-2600(12)70044-9